Detection of malignant pleural effusions by tumor marker evaluation
Authors:
- 1 June 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (6) , 1005-1011
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunoradiometric assay of CA 125 in effusions comparison with carcinoembryonic antigenCancer, 1987
- The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignanciesEuropean Journal of Cancer and Clinical Oncology, 1985
- Pleural fluid ferritin concentrations in human disease.Journal of Clinical Pathology, 1985
- Diagnostic value of tumoral markers in serous effusions. Carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and Beta2-microglobulinCancer, 1982
- Combined effusion fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (HCG), in the detection of malignant tumorsCancer, 1981
- Diagnostic Value of Biochemical Analysis of Pleural Effusions: Carcinoembryonic Antigen and Beta2MicroglobulinAmerican Journal of Clinical Pathology, 1979
- Cytology of Serous Effusions: An Investigation into the Usefulness of Cell Blocks versus SmearsAmerican Journal of Clinical Pathology, 1978
- CONCURRENT ASSAYS OF PLASMA AND PLEURAL-EFFUSION LEVELS OF CARCINOEMBRYONIC ANTIGEN IN THE DIAGNOSIS OF PULMONARY DISEASEThe Lancet, 1978
- Correlations among serum protein-bound carbohydrates, serum glycoproteins, lymphocyte reactivity, and tumor burden in cancer patientsCancer, 1977
- Les glycoproteines des liquides pleurauxClinica Chimica Acta, 1977